Caris Life Sciences (CAI)
15.38
-0.35 (2.23%)
Upcoming Events
Latest Headlines
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
July 16, 2026 8:30 AM - PR NewsWire
Caris Life Sciences to offer PTEN IHC testing for prostate cancer
July 14, 2026 8:31 AM - StreetInsider
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing
July 14, 2026 8:30 AM - PR NewsWire
Caris Life Sciences Inc (CAI) PT Raised to $23 at Baird
July 13, 2026 7:18 AM - StreetInsider
Form 4 Caris Life Sciences, For: May 15 Filed by: HALBERT JON
July 13, 2026 7:06 AM - SEC Filing
BTIG Reiterates Buy Rating on Caris Life Sciences Inc (CAI)
July 2, 2026 6:16 AM - StreetInsider
Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test
July 1, 2026 8:30 AM - PR NewsWire
Form CERT Caris Life Sciences,
June 16, 2026 11:10 AM - SEC Filing
Form 8-A12B Caris Life Sciences,
June 16, 2026 10:47 AM - SEC Filing
Caris Life Sciences dual-lists on NYSE Texas under CAI ticker
June 16, 2026 8:31 AM - StreetInsider
Caris Life Sciences Announces Dual Listing on NYSE Texas
June 16, 2026 8:30 AM - PR NewsWire
Caris Life Sciences authorizes $100 million share repurchase program
June 8, 2026 8:30 AM - StreetInsider
Caris Life Sciences Announces Share Repurchase Program
June 8, 2026 8:30 AM - PR NewsWire
Form 8-K Caris Life Sciences, For: Jun 04
June 5, 2026 5:04 PM - SEC Filing
Form 4 Caris Life Sciences, For: May 29 Filed by: POSTE GEORGE
June 2, 2026 5:44 PM - SEC Filing
Form 4 Caris Life Sciences, For: May 29 Filed by: Knowles Jonathan Kenneth Charles
June 2, 2026 5:43 PM - SEC Filing
Wolfe Research Assumes Caris Life Sciences Inc (CAI) at Peerperform
June 1, 2026 4:01 PM - StreetInsider
Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing
May 26, 2026 8:30 AM - PR NewsWire
Form 4 Caris Life Sciences, For: May 15 Filed by: Denton John Russel
May 18, 2026 4:29 PM - SEC Filing
Form 4 Caris Life Sciences, For: May 15 Filed by: Power Luke Thomas
May 18, 2026 4:28 PM - SEC Filing
Form 4 Caris Life Sciences, For: May 15 Filed by: Brille Brian J
May 18, 2026 4:28 PM - SEC Filing
Form 4 Caris Life Sciences, For: May 15 Filed by: Spetzler David Baxley
May 18, 2026 4:28 PM - SEC Filing
Form 4 Caris Life Sciences, For: May 15 Filed by: HALBERT DAVID D
May 18, 2026 4:28 PM - SEC Filing
Caris Life Sciences study identifies 13,293 patients for new cancer therapies
May 15, 2026 8:32 AM - StreetInsider
Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek
May 15, 2026 8:30 AM - PR NewsWire
Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities
May 13, 2026 8:30 AM - Globe NewsWire
Form SCHEDULE 13G/A Caris Life Sciences, Filed by: TSSP Sub-Fund HoldCo LLC
May 12, 2026 4:31 PM - SEC Filing
Form SCHEDULE 13G/A Caris Life Sciences, Filed by: J H Whitney VI L P
May 12, 2026 10:48 AM - SEC Filing
Form 4 Caris Life Sciences, For: May 11 Filed by: Vacirca Jeff L
May 12, 2026 8:22 AM - SEC Filing
Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels
May 11, 2026 12:15 PM - PR NewsWire
Form 10-Q Caris Life Sciences, For: Mar 31
May 8, 2026 4:14 PM - SEC Filing
Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization
May 8, 2026 4:05 PM - PR NewsWire
Caris Life Sciences Inc (CAI) PT Lowered to $22 at Baird
May 8, 2026 7:55 AM - StreetInsider
Form 8-K Caris Life Sciences, For: May 07
May 7, 2026 4:17 PM - SEC Filing
CAI International (CAI) Tops Q1 EPS by 12c ; Offers Guidance
May 7, 2026 4:11 PM - StreetInsider
Caris Life Sciences Reports First Quarter 2026 Financial Results
May 7, 2026 4:05 PM - PR NewsWire
Caris Life Sciences launches AI-powered breast cancer recurrence test
May 5, 2026 8:32 AM - StreetInsider
Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis
May 5, 2026 8:30 AM - PR NewsWire
Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies
May 4, 2026 8:30 AM - PR NewsWire
Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma Patients
April 29, 2026 8:30 AM - PR NewsWire
Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference
April 24, 2026 8:30 AM - PR NewsWire
Form ARS Caris Life Sciences, For: Dec 31
April 23, 2026 6:25 AM - SEC Filing
Form DEFA14A Caris Life Sciences,
April 23, 2026 6:24 AM - SEC Filing
Form DEF 14A Caris Life Sciences, For: Jun 04
April 23, 2026 6:24 AM - SEC Filing
Full Article List
